1. Both robotic and open surgery achieve similar results at 3 months
The first stage of a two year study published in the Lancet, reports that both robot-assisted laparoscopic prostatectomy (RALP) and radical retropubic prostatectomy (open) surgery for localized prostate cancer achieve similar outcomes at 3 months. This Australian study, composed of 308 men, is the first randomised controlled trial to compare robotic vs open surgery for the treatment of localized prostate cancer. There was no significant difference between open vs RALP groups at 12 weeks post surgery for urinary (83.80 vs 82.50; p=0.48) or sexual (35.00 vs 38.90; p=0.18) function or proportion of positive surgical margins (10% vs 15%; p=0.21). There was a tendency, which did not reach statistical significance (p=0.052), towards lower postoperative complications in the RALP group (2%) compared to open surgery (8%). According to the 2014 BAUS Surgical audit of radical prostatectomies in the UK, RALP accounted for 59% of surgeries, while open surgeries were performed in 13.4% of the cases. Reporting on longer-term follow, at 24 months post-surgery, is expected, and will include analysis of urinary and sexual function and oncological outcomes including positive surgical margin status and evidence of progression. This will be important to fully assess the efficacy of both treatments in terms of long-term side-effects and cancer survival.
You can read more about this study on the news section of our website here.